Transportation cost as a barrier to contraceptive use among women initiating treatment for HIV in Tanzania.
Lauren A HunterNdola PrataBrenda EskenaziProsper F NjauSandra I McCoyPublished in: AIDS care (2020)
Transportation cost is a barrier to HIV treatment, yet no studies have examined its association with contraceptive use among women living with HIV. We analyzed cross-sectional data from women attending three public healthcare facilities in Shinyanga, Tanzania where they initiated antiretroviral therapy for HIV infection in the previous 90 days; all facilities offered free contraception. Women self-reported current contraceptive use and the round-trip cost of transportation to the facility. Among 421 women aged 18-49, 86 (20.4%) were using any modern contraceptive method, of which half were using modern methods other than condoms. Women who paid more than 2,000 Tanzanian shillings for transportation had a significantly lower prevalence of any modern method use than women who paid nothing (9.1% vs. 21.3%; adjusted difference: -12.9; 95% confidence interval: -21.3, -4.4). A similar difference was observed for non-condom modern method use. We conclude that high transportation cost may impede contraceptive use even among women accessing HIV treatment.
Keyphrases
- polycystic ovary syndrome
- healthcare
- antiretroviral therapy
- pregnancy outcomes
- hiv infected
- hiv positive
- human immunodeficiency virus
- cervical cancer screening
- cross sectional
- breast cancer risk
- hepatitis c virus
- hiv aids
- men who have sex with men
- hiv testing
- emergency department
- pregnant women
- machine learning
- adipose tissue
- mental health
- metabolic syndrome
- health information
- big data
- health insurance